| scholarly article | Q13442814 |
| P50 | author | Herbert L. DuPont | Q29563314 |
| P2093 | author name string | Natalia Khalaf | |
| Hoonmo L Koo | |||
| Jonathan D Crews | |||
| P2860 | cites work | Development of the human infant intestinal microbiota | Q21003936 |
| Clostridium difficile toxins: mechanism of action and role in disease | Q24522454 | ||
| Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty? | Q26827536 | ||
| A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease | Q28254686 | ||
| Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. | Q33968261 | ||
| Treatment with monoclonal antibodies against Clostridium difficile toxins | Q34093904 | ||
| Fidaxomicin versus vancomycin for Clostridium difficile infection | Q34162172 | ||
| Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. | Q34196731 | ||
| Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children | Q34381763 | ||
| A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality | Q34472139 | ||
| An epidemic, toxin gene-variant strain of Clostridium difficile | Q34472146 | ||
| Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile | Q34530913 | ||
| Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol | Q34620553 | ||
| A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity | Q34643123 | ||
| Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea | Q34736772 | ||
| Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital | Q34741501 | ||
| Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review | Q34870413 | ||
| Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin | Q34880915 | ||
| Asymptomatic neonatal colonisation by Clostridium difficile | Q35117848 | ||
| Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients | Q35579344 | ||
| The epidemiology of community-acquired Clostridium difficile infection: a population-based study | Q35740811 | ||
| Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor | Q35821556 | ||
| Clostridium difficile infections among hospitalized children, United States, 1997-2006. | Q35997539 | ||
| Incidence and origin of Clostridium difficile in neonates | Q37259772 | ||
| Influence of age, sex, and diet on asymptomatic colonization of infants with Clostridium difficile | Q37306824 | ||
| Clostridium difficile: development of a novel candidate vaccine | Q38017389 | ||
| Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis | Q39600494 | ||
| Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea | Q39636517 | ||
| Alterations in human fecal flora, including ingrowth of Clostridium difficile, related to cefoxitin therapy | Q39833488 | ||
| A case-control study of community-associated Clostridium difficile infection | Q39844072 | ||
| Antibiotic-associated colitis—A review of 66 cases | Q40019318 | ||
| Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. | Q40022729 | ||
| Application of typing by pulsed-field gel electrophoresis to the study of Clostridium difficile in a neonatal intensive care unit | Q40179932 | ||
| Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study. | Q40613143 | ||
| Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial | Q40654528 | ||
| Prolonged carriage of Clostridium difficile in Hirschsprung's disease | Q41766353 | ||
| Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. | Q43202806 | ||
| Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile | Q43284141 | ||
| Diagnostic role of stool culture & toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children. | Q43502262 | ||
| Presence of the epidemic North American Pulsed Field type 1 Clostridium difficile strain in hospitalized children | Q43671707 | ||
| Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000-2005. | Q43949644 | ||
| Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England | Q44087982 | ||
| Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection | Q44485712 | ||
| The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences | Q44537417 | ||
| Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile | Q45164970 | ||
| Clostridium difficile-associated diarrhea in 200 Canadian children | Q46656678 | ||
| Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding | Q49187253 | ||
| The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. | Q51221306 | ||
| A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection. | Q51533711 | ||
| The potential for airborne dispersal of Clostridium difficile from symptomatic patients. | Q52847775 | ||
| Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level? | Q54354899 | ||
| Diarrhea in American infants and young children in the community setting: incidence, clinical presentation and microbiology. | Q54472618 | ||
| Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. | Q54492451 | ||
| Prevalence and diversity of Clostridium difficile strains in infants | Q57006281 | ||
| Host and Pathogen Factors forClostridium difficileInfection and Colonization | Q58924088 | ||
| Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe | Q58924160 | ||
| Impact of Clostridium difficile Infection on Pediatric Inflammatory Bowel Disease | Q62051573 | ||
| Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI). | Q64961173 | ||
| Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. | Q64993981 | ||
| Clostridium difficile in neonates: serogrouping and epidemiology | Q68256964 | ||
| Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain | Q68988457 | ||
| Significance of Clostridium difficile and its cytotoxin in children | Q70029014 | ||
| Epidemiology of Clostridium difficile in infants | Q70516780 | ||
| Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations | Q70794622 | ||
| Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants | Q71115213 | ||
| Chronic diarrhea associated with Clostridium difficile in children | Q71657728 | ||
| Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea | Q73523895 | ||
| Colonization of infants and hospitalized patients with Clostridium difficile and lactobacilli | Q73732420 | ||
| Possible role of cross-transmission between neonates and mothers with recurrent Clostridium difficile infections | Q77841833 | ||
| Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea | Q81400778 | ||
| Changing epidemiology of Clostridium difficile-associated disease in children | Q81416962 | ||
| Clostridium difficile-associated disease in children with solid tumors | Q81999393 | ||
| Risk factors and outcomes associated with severe clostridium difficile infection in children | Q82226822 | ||
| Strategies to prevent clostridium difficile infections in acute care hospitals | Q82229599 | ||
| Epidemiology and risk factors for Clostridium difficile infection in children | Q83202730 | ||
| Saccharomyces boulardii in a child with recurrent Clostridium difficile | Q83663575 | ||
| P433 | issue | 75 | |
| P921 | main subject | Clostridium difficile | Q310543 |
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 105-113 | |
| P577 | publication date | 2012-08-01 | |
| P1433 | published in | Discovery Medicine | Q5281940 |
| P1476 | title | Clostridium difficile: an emerging pathogen in children | |
| P478 | volume | 14 |
Search more.